GAVI

GAVI, also known as the Vaccine Alliance, is a global health partnership committed to increasing access to immunization in poor countries. GAVI brings together public and private sectors with the shared goal of creating equal access to new and underused vaccines for children living in the world's poorest countries.

History[edit | edit source]

GAVI was created in 2000 as a response to stagnating immunization rates and widening disparities in vaccine access among countries. The organization was formed to bring together the best of what key UN agencies, governments, the vaccine industry, private sector and civil society had to offer in order to improve childhood immunization coverage in poor countries and to accelerate access to new vaccines.

Funding[edit | edit source]

GAVI is funded by governments (Australia, Canada, Denmark, France, Germany, India, Ireland, Italy, Japan, the Kingdom of Saudi Arabia, Luxembourg, the Netherlands, Norway, the People's Republic of China, Republic of Korea, Russia, South Africa, Spain, the State of Qatar, the Sultanate of Oman, Sweden, United Kingdom, and United States), the European Commission, His Highness Sheikh Mohamed bin Zayed Al Nahyan, as well as private and corporate partners (Absolute Return for Kids, Anglo American plc., The Children’s Investment Fund Foundation, Comic Relief, the ELMA Vaccines and Immunization Foundation, the Bill & Melinda Gates Foundation, The Gulf Youth Alliance, JP Morgan, "la Caixa" Foundation, LDS Charities, Lions Clubs International Foundation, and Majid Al Futtaim).

Impact[edit | edit source]

Since its inception, GAVI has helped vaccinate more than 822 million children in the world's poorest countries, preventing more than 14 million future deaths.

See also[edit | edit source]

Template:Global health Template:Immunization

GAVI Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.